Latest Breaking News On - அலுவலகம் ஆஃப் ஜெநெரிக் மருந்துகள் - Page 1 : comparemela.com

United States Generic Drugs Market will be US$ 239.5 Billion by 2026. Generics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects. In the United States, generic drug production has increased because it is cheaper than any branded medicine. From the last 3 decades, U.S generic drug market has transformed from less than 20% of generic drug prescription to 80% of dispensing generic medicine prescriptions.  Generic medicines help maintain the country s healthcare system, from curing patients to saving money. Currently, the price of off-label drugs is 70% to 80% lower than branded medicines. In the United States, the decline in medicine price works as the biggest catalyst for the generic drug market growth. These generic medicines prices sometimes declined to 85% less than patented drugs; this happens when various generic drug companies target a single patented drug. the resea

United statesLaura woodEndo pharmaceuticalsOffice hours callGeneric drug companiesSandoz incDrug evaluation in researchTeva pharmaceutical industries ltdE st office hours callOffice of generic drugsCompany analysisStates generic drugs market by segmentTherapeutic applicationStates generic drugs marketUnited states off label drugs marketGeneric drugs